But, unlike NASH, where damage worsens with time, SRSF1 HKO liver injury subsided with age and, except for the intrahepatic fibrosis, the mice recovered as SRSF1-expressing hepatocytes repopulated the liver (Fig. 3; Supplementary Table 2). This evidence concerns the gene SRSF1 and metabolic dysfunction-associated steatohepatitis.